Carregant...
Use of Lacosamide in Children with Refractory Epilepsy
OBJECTIVES: Lacosamide was approved by the US Food and Drug Administration in 2008 for adjunctive therapy for focal onset seizures in patients 17 years of age and older. The efficacy of this agent in adults has led clinicians to consider lacosamide for children with refractory seizures. METHODS: The...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pediatric Pharmacy Advocacy Group
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3526924/ https://ncbi.nlm.nih.gov/pubmed/23258963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-17.3.211 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|